Adagene Inc (ADAG)
2.25
-0.14
(-5.86%)
USD |
NASDAQ |
Apr 29, 16:00
2.22
-0.03
(-1.33%)
After-Hours: 06:45
Adagene Enterprise Value: 11.36M for April 29, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 29, 2024 | 11.36M |
| April 26, 2024 | 17.54M |
| April 25, 2024 | 15.77M |
| April 24, 2024 | 33.43M |
| April 23, 2024 | 29.02M |
| April 22, 2024 | 32.55M |
| April 19, 2024 | 28.58M |
| April 18, 2024 | 28.58M |
| April 17, 2024 | 23.72M |
| April 16, 2024 | 31.23M |
| April 15, 2024 | 26.81M |
| April 12, 2024 | 28.75M |
| April 11, 2024 | 36.53M |
| April 10, 2024 | 44.03M |
| April 09, 2024 | 44.03M |
| April 08, 2024 | 36.97M |
| April 05, 2024 | 37.85M |
| April 04, 2024 | 46.68M |
| April 03, 2024 | 40.06M |
| April 02, 2024 | 44.47M |
| April 01, 2024 | 55.07M |
| March 28, 2024 | 35.64M |
| March 27, 2024 | 24.60M |
| March 26, 2024 | 22.84M |
| March 25, 2024 | 25.04M |
| Date | Value |
|---|---|
| March 22, 2024 | 23.28M |
| March 21, 2024 | 27.25M |
| March 20, 2024 | 37.85M |
| March 19, 2024 | 36.08M |
| March 18, 2024 | 40.06M |
| March 15, 2024 | 37.63M |
| March 14, 2024 | 38.29M |
| March 13, 2024 | 36.97M |
| March 12, 2024 | 43.15M |
| March 11, 2024 | 40.28M |
| March 08, 2024 | 36.53M |
| March 07, 2024 | 37.85M |
| March 06, 2024 | 38.73M |
| March 05, 2024 | 51.10M |
| March 04, 2024 | 48.89M |
| March 01, 2024 | 56.84M |
| February 29, 2024 | 53.31M |
| February 28, 2024 | 54.50M |
| February 27, 2024 | 56.71M |
| February 26, 2024 | 61.12M |
| February 23, 2024 | 56.26M |
| February 22, 2024 | 65.09M |
| February 21, 2024 | 50.97M |
| February 20, 2024 | 53.62M |
| February 16, 2024 | 46.12M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-112.38M
Minimum
Oct 31 2022
1.198B
Maximum
Feb 09 2021
123.62M
Average
-27.11M
Median
Nov 30 2023
Enterprise Value Benchmarks
| Sinovac Biotech Ltd | -- |
| CASI Pharmaceuticals Inc | 19.49M |
| Zai Lab Ltd | 792.79M |
| I-MAB | -172.81M |
| Gracell Biotechnologies Inc (DELISTED) | -- |
Enterprise Value Related Metrics
| Earnings Yield | -19.44% |
| Normalized Earnings Yield | -20.51 |